762 related articles for article (PubMed ID: 15198370)
1. C-peptide, Na+,K(+)-ATPase, and diabetes.
Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
[TBL] [Abstract][Full Text] [Related]
2. Effects of C-peptide on microvascular blood flow and blood hemorheology.
Forst T; Kunt T
Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
[TBL] [Abstract][Full Text] [Related]
3. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
[TBL] [Abstract][Full Text] [Related]
4. [Genetic factors, Na K ATPase activity and neuropathy in diabetics].
Vague P; Dufayet D; Lamotte MF; Mouchot C; Raccah D
Bull Acad Natl Med; 1997 Dec; 181(9):1811-21; discussion 1821-3. PubMed ID: 9611401
[TBL] [Abstract][Full Text] [Related]
5. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
Raccah D; Gallice P; Pouget J; Vague P
Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
[TBL] [Abstract][Full Text] [Related]
6. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
Nordquist L; Shimada K; Ishii T; Furuya DT; Kamikawa A; Kimura K
Diabetes Metab Res Rev; 2010 Mar; 26(3):193-9. PubMed ID: 20225182
[TBL] [Abstract][Full Text] [Related]
7. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
Djemli-Shipkolye A; Coste T; Raccah D; Vague P; Pieroni G; Gerbi A
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004
[TBL] [Abstract][Full Text] [Related]
8. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
[TBL] [Abstract][Full Text] [Related]
9. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney.
Raccah D; Lamotte-Jannot MF; Issautier T; Vague P
Diabete Metab; 1994; 20(3):271-4. PubMed ID: 8001715
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of omega3 PUFA supplementations on Na,K-ATPase and Mg-ATPase activities: possible role of the membrane omega6/omega3 ratio.
Djemli-Shipkolye A; Raccah D; Pieroni G; Vague P; Coste TC; Gerbi A
J Membr Biol; 2003 Jan; 191(1):37-47. PubMed ID: 12532275
[TBL] [Abstract][Full Text] [Related]
11. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetic neuropathy and C-peptide.
Sima AA; Zhang W; Grunberger G
Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
[TBL] [Abstract][Full Text] [Related]
14. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
Shahid SM; Mahboob T
Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic hyperglycemia and vanadate treatment on erythrocyte Na/K-ATpase and Mg-ATpase in streptozotocin diabetic rats.
Totan AR; Greabu M
Acta Pol Pharm; 2002; 59(4):307-11. PubMed ID: 12403306
[TBL] [Abstract][Full Text] [Related]
16. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
[TBL] [Abstract][Full Text] [Related]
17. Altered expression and insulin-induced trafficking of Na+-K+-ATPase in rat skeletal muscle: effects of high-fat diet and exercise.
Galuska D; Kotova O; Barrès R; Chibalina D; Benziane B; Chibalin AV
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E38-49. PubMed ID: 19366873
[TBL] [Abstract][Full Text] [Related]
18. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
19. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
[TBL] [Abstract][Full Text] [Related]
20. Electrolytes and sodium transport mechanism in diabetes mellitus.
Shahid SM; Rafique R; Mahboob T
Pak J Pharm Sci; 2005 Apr; 18(2):6-10. PubMed ID: 16431390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
